News for Cipher Pharmaceuticals Inc. (CPH.TO)

\nInvestment rationale centers on strategic acquisitions and cash-rich balance sheet.Market positioning strengthened by recent acquisition of Natroba and US sale

Stephen Lemieux appointed as President of NeuPath Health Inc. (TSXV:NPTH), effective May 1, 2025. Lemieux brings over 20 years of experience in healthca

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therape

**media[586399]**

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q4 2024 earnings on Mar 18, 2025. The consensus estimate for Q4 2024 revenue is $17.92 million, and t

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q4 2024 earnings on Mar 19, 2025. The consensus estimate for Q4 2024 revenue is $17.92 million, and t

Total Net Revenue (Q4 2024): $11.8 million, up 141% from the prior year.Product Revenue (Q4 2024): $10.5 million, up 209% from the prior year.Natroba Revenue (

Mar 19, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference cal

The following slide deck was published by Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsCraig Mull - Interim CEORyan...

Donville Kent Asset Management's DKCI Fund returned 102.75% in 2024. The fund has performed well since bottoming in October 2023. Click here to read the full letter.

Total Net Revenue (Q3 2024): $10.4 million, a 71% increase compared to the same quarter in the prior year.Total Net Revenue (9 months ended September 30, 2024)

Nov 08, 2024 / 01:30PM GMTOperator Good morning, ladies and gentlemen. And thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $14.60 million, and th

May 10, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ETCompany ParticipantsCraig J.

MANAGEMENT'S DISCUSSION AND ANALYSIS For the three months ended March 31, 2024 MANAGEMENT'S DISCUSSION AND ANALYSIS ...

Cipher Pharmaceuticals will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. ...

Mar 15, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, thank you for standing by, and welcome to the Cipher Pharmaceuticals Fourth Quarter and F